Is banning direct to consumer advertising of prescription medicine justified paternalism?
Journal of Bioethical Inquiry 2 (2) (2005)
| Abstract | New Zealand is one of two OECD countries in the world where direct-to-consumer advertising of prescription medicine (DTCA-PM) is permitted. Increase in such activity in recent years has resulted in a disproportionate increase in dispensary volume of heavily advertised medicines. Concern for the potential harm to healthcare consumers and the public healthcare system has prompted the medical profession to call for a ban on DTCA-PM as the best way of protecting the public interest. Such blanket prohibition however also interferes with the public’s right of access to information. This paper will examine if banning DTCA-PM would constitute a justified form of paternalism in the context of today’s New Zealand. | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,709 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesDaniel Attas (1999). What's Wrong with "Deceptive" Advertising? Journal of Business Ethics 21 (1):49 - 59.
Andreas Hasman & Søren Holm (2005). Direct-to-Consumer Advertising: Should There Be a Free Market in Healthcare Information? Cambridge Quarterly of Healthcare Ethics 15 (01).
Ashish Chandra & Gary A. Holt (1999). Pharmaceutical Advertisements: How They Deceive Patients. Journal of Business Ethics 18 (4):359 - 366.
Rosa Lynn B. Pinkus (2002). From Lydia Pinkham to Bob Dole: What the Changing Face of Direct-to-Consumer Drug Advertising Reveals About the Professionalism of Medicine. Kennedy Institute of Ethics Journal 12 (2):141-158.
R. Stephen Parker & Charles E. Pettijohn (2003). Ethical Considerations in the Use of Direct-to-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians. Journal of Business Ethics 48 (3):279-290.
Christopher Jordens & Lynley Anderson (2005). Should We Be Concerned About Direct-to-Consumer Advertising of Prescription Drugs? Journal of Bioethical Inquiry 2 (2).
Richard F. Beltramini (2006). Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs. Journal of Business Ethics 63 (4):333 - 343.
Pepijn K. C. van de Pol & Frank G. A. de Bakker (forthcoming). Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility? Journal of Business Ethics.
Betty B. Chaar & Johnson Lee (2012). Role of Socioeconomic Status on Consumers' Attitudes Towards DTCA of Prescription Medicines in Australia. Journal of Business Ethics 105 (4):447-460.
Analytics
Monthly downloads |
Added to index2009-01-28Total downloads23 ( #53,940 of 549,753 )Recent downloads (6 months)1 ( #63,425 of 549,753 )How can I increase my downloads? |
My notes
Discussion
